Vaccine stock to climb up to $140 in wave-3
At a weekly time frame, this stock is the next thing to blow out. With phase 3 trials expected in July, the potential of 
MRNA could be huge in upcoming weeks.
With wave-1 and wave-2 already formed, market is now forming wave-3 which may lead the price to possibly $140-160 zone.
(Note: Please ignore the markings for wave-4 and wave-5)
What do you think about this idea? Leave your comments below.
Disclaimer: This is not a financial advise. Please make your independent decisions while making an investment.
MRNA could be huge in upcoming weeks.With wave-1 and wave-2 already formed, market is now forming wave-3 which may lead the price to possibly $140-160 zone.
(Note: Please ignore the markings for wave-4 and wave-5)
What do you think about this idea? Leave your comments below.
Disclaimer: This is not a financial advise. Please make your independent decisions while making an investment.
Trade aktif
Trading ditutup secara manual
Trade was closed earlier in August when MRNA made a high of $95.21 and then dropped back to 60s breaking the trend line.
Pernyataan Penyangkalan
Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.